首页 > 《心理医生》 > 2011年5期 > 西酞普兰治疗儿童强迫症的疗效观察

西酞普兰治疗儿童强迫症的疗效观察

打印

在线阅读下载PDF 导出详情

摘要 (惠州市中心人民医院心理睡眠门诊广东惠州516001)摘要目的评价西酞普兰治疗儿童强迫症的临床疗效及其不良反应。方法将符合CCMD-3诊断标准的32例儿童强迫症患者每日给予西酞普兰10～20mg,连续治疗8周，分别于入组前、服药2、4、8周末应用Yale-Brown强迫量表(Y-BOCS)，汉密尔顿抑郁量表(HAMD)，汉密尔顿焦虑量表(HAMA)评定疗效，采用副反应量表(TSESS)评定不良反应。结果所有32例患者均完成了8周的临床观察，治疗前后Y-BOCS、HAMD、HAMA分值均显著下降(P<0.01)，不良反应轻微。结论西酞普兰治疗儿童强迫症安全有效，依从性好。

DOI 7dmzk26e4n/2817254

作者朱列和

机构地区朱列和

出处《心理医生》 2011年5期

关键词西酞普兰儿童强迫症Abstract Objective To compare the efficacy and side effects of Cipramil in the treatment of child obsessive-compulsive disorder. Methods Thirty-two cases diagnosed as child obsessive compulse disorders according to CCMD-3 diagnostic criteria were treated with 10～20mg citalopram per day for 8 weeks.The efficacy was measured with Y-BOCS HAMD and HAMA. The side effects were assessed by TESS. Result Clinic observation of all cases is completed. The diffirence of Y-BOCS HAMD and HAMA score before and after treatment is significant(P＜0.01). Conclusive citalopram is safe effective and good in compliance for the treatment of child child obsessive-compulsive disorder.

分类 [医药卫生][医学心理学]

出版日期 2011年05月15日（中国Betway体育网页登陆平台首次上网日期，不代表论文的发表时间）

相关文献

1王永学;龙金亮;孙梅玲.西酞普兰与氯丙咪嗪治疗强迫症对照研究.临床医学,2005-01.
2于俊文.艾司西酞普兰和氯米帕明治疗11例强迫症患者临床疗效观察.公共卫生与预防医学,2014-12.
3赖高平.艾斯西酞普兰合用利培酮治疗强迫症40例.临床医学,2018-12.
4赵献民.艾司西酞普兰与帕罗西汀治疗强迫症的临床分析.医学心理学,2016-02.
5蒋重蓉.西酞普兰与氯米帕明治疗难治性强迫症对照研究.医学心理学,2011-07.
6廖建群.西酞普兰与氯米帕明治疗难治性强迫症对比研究.医学心理学,2011-09.
7马会斌李聪慧李丹.艾司西酞普兰合并氯丙咪嗪治疗强迫症对照研究.公共卫生与预防医学,2016-04.
8杨明辉.艾司西酞普兰对强迫症患者临床疗效及安全性分析.免疫学,2017-03.
9高天飞张雄苑杰.艾司西酞普兰和氯米帕明治疗强迫症临床效果分析.药学,2016-09.
10冯琳.西酞普兰治疗脑卒中抑郁症的疗效观察.医学心理学,2017-12.

来源期刊

心理医生

心理医生

相关推荐

同分类资源更多

相关关键词

西酞普兰儿童强迫症Abstract Objective To compare the efficacy and side effects of Cipramil in the treatment of child obsessive-compulsive disorder. Methods Thirty-two cases diagnosed as child obsessive compulse disorders according to CCMD-3 diagnostic criteria were treated with 10～20mg citalopram per day for 8 weeks.The efficacy was measured with Y-BOCS HAMD and HAMA. The side effects were assessed by TESS. Result Clinic observation of all cases is completed. The diffirence of Y-BOCS HAMD and HAMA score before and after treatment is significant(P＜0.01). Conclusive citalopram is safe effective and good in compliance for the treatment of child child obsessive-compulsive disorder.

返回顶部